BE902308A - Procede de traitement et de prevention de l'osteoporose. - Google Patents

Procede de traitement et de prevention de l'osteoporose.

Info

Publication number
BE902308A
BE902308A BE0/214929A BE214929A BE902308A BE 902308 A BE902308 A BE 902308A BE 0/214929 A BE0/214929 A BE 0/214929A BE 214929 A BE214929 A BE 214929A BE 902308 A BE902308 A BE 902308A
Authority
BE
Belgium
Prior art keywords
bone
osteoporosis
prevention
treatment
during
Prior art date
Application number
BE0/214929A
Other languages
English (en)
Inventor
L Flora
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BE902308A publication Critical patent/BE902308A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procédé pour traiter ou prévenir l'ostéoporose par lequel les cellules osseuses sont amenées en synchronisme au cours d'une période activatrice ds cellules osseuses, la résorption osseuse qui suit normalement l'activation est inhibée en utilisant un polyphosphonate et la formation osseuse est admise à se produire au cours de la période de repos pendant laquelle des suppléments de nutrition peuvent s'administrer au patient.
BE0/214929A 1984-04-30 1985-04-29 Procede de traitement et de prevention de l'osteoporose. BE902308A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60554184A 1984-04-30 1984-04-30
US68454284A 1984-12-21 1984-12-21

Publications (1)

Publication Number Publication Date
BE902308A true BE902308A (fr) 1985-10-29

Family

ID=27084978

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/214929A BE902308A (fr) 1984-04-30 1985-04-29 Procede de traitement et de prevention de l'osteoporose.

Country Status (5)

Country Link
AU (1) AU569391B2 (fr)
BE (1) BE902308A (fr)
DE (1) DE3514584A1 (fr)
IT (1) IT1188160B (fr)
PH (1) PH21642A (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU568433B2 (en) * 1984-04-30 1987-12-24 Procter & Gamble Company, The Treating osteoporosis
EP0381296B1 (fr) * 1984-04-30 1994-11-30 THE PROCTER & GAMBLE COMPANY Equipement pour utilisation dans le traitement de l'ostéoporose
DD285240A7 (de) * 1988-09-27 1990-12-12 Technisches Glas Veb K Verfahren zur herstellung eines osteoinduktiven knochenersatzmaterials
HUT75224A (en) * 1993-10-19 1997-04-28 Merck & Co Inc Combination of bisphosphonates and growth hormone secretagogues

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4330537A (en) * 1977-12-07 1982-05-18 The Procter & Gamble Company Compositions for inhibiting mobilization of calcium phosphate in animal tissue
DE3243358A1 (de) * 1982-11-24 1984-05-24 Rolf Dieter Prof.Dr. 3004 Isernhagen Hesch Synthetisches humanes (1-38) parathormon-fragment, verfahren zu seiner herstellung und die verwendung zur behandlung der osteoporose
AU568433B2 (en) * 1984-04-30 1987-12-24 Procter & Gamble Company, The Treating osteoporosis
EP0381296B1 (fr) * 1984-04-30 1994-11-30 THE PROCTER & GAMBLE COMPANY Equipement pour utilisation dans le traitement de l'ostéoporose

Also Published As

Publication number Publication date
PH21642A (en) 1988-01-13
AU4148485A (en) 1985-11-07
IT1188160B (it) 1988-01-07
DE3514584A1 (de) 1985-10-31
IT8520448A1 (it) 1986-10-23
IT8520448A0 (it) 1985-04-23
AU569391B2 (en) 1988-01-28

Similar Documents

Publication Publication Date Title
ATE258065T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen
AU6760987A (en) Method of treating alzheimer's disease
EP0553291A4 (en) Treatment of autoimmune diseases by oral administration of autoantigens
BE901915A (fr) Procede pour le traitement ou la prevention des maladies provoques par l'acether du facteur d'activation des plaquettes.
HU9302407D0 (en) Preparatives for treating osteoporosis
EP0261814A3 (en) Therapeutic composition and method
PL253202A1 (en) Method of obtaining 2-amino-3-etoxycarbonylamino-6-/p-fluorobenzylamino/-pyridine gluconate
BE902307A (fr) Procede de traitement et de prevention de l'osteoporose.
ATE135914T1 (de) Aica riboside zur prophylaktischen behandlung von krankheiten mit einer verminderten durchblutung.
BE902308A (fr) Procede de traitement et de prevention de l'osteoporose.
KR970009582B1 (en) Method for the treatment of oste oporosis and related disorders
EP0305181A3 (en) Ethyl-(+)-apovincaminate for treating demyelinization clinical patterns of autoimmune origin
CZ28395A3 (en) Therapeutic composition containing whey protein concentrate
HU890380D0 (en) Process for producing (mercapto-acyl)-amino acid derivatives and pharmaceutical preparatives containing these compounds
UA19335A (uk) Спосіб приготуваhhя засобу для лікуваhhя хвороб типу псоріазу
UA19674A (uk) Композиція для обробки коhтактhих ліhз
AU2824289A (en) Thienotricyclene for the treatment of bronchial diseases
LTIP1750A (en) Method for biological treatment of waste water
ATE108664T1 (de) Verfahren zur verhütung von gvhd.
FR2563727B3 (fr) Nouveau procede de preparation de greffon de peau a partir d'un tissu conjonctif natif
FR2624019B1 (fr) Preparation pour la regulation physiologique du systeme neuro-endocrinien, la stimulation de l'immunite, et l'inhibition de la croissance des tumeurs hormono-dependantes, et procede d'obtention de cette preparation.
LTIP1535A (en) Method for treatment of skins and hides
AU7491487A (en) Method of treating ischaemic vascular diseases using 4(benz-oxa/thia-diazole) -14-dihydropyridine der.
IL67802A (en) Process for controlling patterns of chemical stimuli administration to biological tissue
SU1572579A1 (ru) Cпocoб лeчehия дeфopmaций пepeдheгo otдeлa ctoпы

Legal Events

Date Code Title Description
RE Patent lapsed

Effective date: 20040430